National Institutes of Health
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) is a funding opportunity from National Institutes of Health, closing January 29, 2027.
Overview
The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting the development of human microphysiologic systems (MPS) for infectious disease research and the development of therapeutics or biological products. MPS are in vitro platforms composed of cells or tissues…